These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23529008)

  • 21. Reduced expression of synapsin II in a chronic phencyclidine preclinical rat model of schizophrenia.
    Thomson S; Dyck B; Daya R; Ho J; Bernardo A; Tian Y; Mishra RK
    Synapse; 2019 May; 73(5):e22084. PubMed ID: 30582667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavioral abnormalities in synapsin II knockout mice implicate a causal factor in schizophrenia.
    Dyck BA; Skoblenick KJ; Castellano JM; Ki K; Thomas N; Mishra RK
    Synapse; 2009 Aug; 63(8):662-72. PubMed ID: 19360855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for enhanced androgen action in the prefrontal cortex of people with bipolar disorder but not schizophrenia or major depressive disorder.
    Owens SJ; Purves-Tyson TD; Webster MJ; Shannon Weickert C
    Psychiatry Res; 2019 Oct; 280():112503. PubMed ID: 31446215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A role for synapsin in FKBP51 modulation of stress responsiveness: Convergent evidence from animal and human studies.
    Schmidt U; Buell DR; Ionescu IA; Gassen NC; Holsboer F; Cox MB; Novak B; Huber C; Hartmann J; Schmidt MV; Touma C; Rein T; Herrmann L
    Psychoneuroendocrinology; 2015 Feb; 52():43-58. PubMed ID: 25459892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced neuronal expression of insulin-degrading enzyme in the dorsolateral prefrontal cortex of patients with haloperidol-treated, chronic schizophrenia.
    Bernstein HG; Ernst T; Lendeckel U; Bukowska A; Ansorge S; Stauch R; Have ST; Steiner J; Dobrowolny H; Bogerts B
    J Psychiatr Res; 2009 Sep; 43(13):1095-105. PubMed ID: 19394958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in cortical N-methyl-D-aspartate receptors and post-synaptic density protein 95 in schizophrenia, mood disorders and suicide.
    Dean B; Gibbons AS; Boer S; Uezato A; Meador-Woodruff J; Scarr E; McCullumsmith RE
    Aust N Z J Psychiatry; 2016 Mar; 50(3):275-83. PubMed ID: 26013316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RGS4 mRNA expression in postmortem human cortex is associated with COMT Val158Met genotype and COMT enzyme activity.
    Lipska BK; Mitkus S; Caruso M; Hyde TM; Chen J; Vakkalanka R; Straub RE; Weinberger DR; Kleinman JE
    Hum Mol Genet; 2006 Sep; 15(18):2804-12. PubMed ID: 16905560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. H3K4 tri-methylation in synapsin genes leads to different expression patterns in bipolar disorder and major depression.
    Cruceanu C; Alda M; Nagy C; Freemantle E; Rouleau GA; Turecki G
    Int J Neuropsychopharmacol; 2013 Mar; 16(2):289-99. PubMed ID: 22571925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synapsin III gene polymorphisms and schizophrenia.
    Ohmori O; Shinkai T; Hori H; Kojima H; Nakamura J
    Neurosci Lett; 2000 Jan; 279(2):125-7. PubMed ID: 10674637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Schizophrenia and bipolar disorder: findings from studies of the Stanley Foundation Brain Collection.
    Knable MB
    Schizophr Res; 1999 Sep; 39(2):149-52; discussion 163. PubMed ID: 10507526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysbindin-1 contributes to prefrontal cortical dendritic arbor pathology in schizophrenia.
    Konopaske GT; Balu DT; Presti KT; Chan G; Benes FM; Coyle JT
    Schizophr Res; 2018 Nov; 201():270-277. PubMed ID: 29759351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temporal, Diagnostic, and Tissue-Specific Regulation of NRG3 Isoform Expression in Human Brain Development and Affective Disorders.
    Paterson C; Wang Y; Hyde TM; Weinberger DR; Kleinman JE; Law AJ
    Am J Psychiatry; 2017 Mar; 174(3):256-265. PubMed ID: 27771971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder.
    Beneyto M; Meador-Woodruff JH
    Neuropsychopharmacology; 2008 Aug; 33(9):2175-86. PubMed ID: 18033238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positive association between synapsin II and schizophrenia.
    Chen Q; He G; Wang XY; Chen QY; Liu XM; Gu ZZ; Liu J; Li KQ; Wang SJ; Zhu SM; Feng GY; He L
    Biol Psychiatry; 2004 Aug; 56(3):177-81. PubMed ID: 15271586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased expression in dorsolateral prefrontal cortex of CAPON in schizophrenia and bipolar disorder.
    Xu B; Wratten N; Charych EI; Buyske S; Firestein BL; Brzustowicz LM
    PLoS Med; 2005 Oct; 2(10):e263. PubMed ID: 16146415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment.
    Snitz BE; MacDonald A; Cohen JD; Cho RY; Becker T; Carter CS
    Am J Psychiatry; 2005 Dec; 162(12):2322-9. PubMed ID: 16330597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An RT-PCR study of 5-HT(6) and 5-HT(7) receptor mRNAs in the hippocampal formation and prefrontal cortex in schizophrenia.
    East SZ; Burnet PW; Kerwin RW; Harrison PJ
    Schizophr Res; 2002 Sep; 57(1):15-26. PubMed ID: 12165372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential distribution of synapsin IIa and IIb mRNAs in various brain structures and the effect of chronic morphine administration on the regional expression of these isoforms.
    Matus-Leibovitch N; Nevo I; Vogel Z
    Brain Res Mol Brain Res; 1997 May; 45(2):301-16. PubMed ID: 9149105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3.
    Föcking M; Dicker P; English JA; Schubert KO; Dunn MJ; Cotter DR
    Arch Gen Psychiatry; 2011 May; 68(5):477-88. PubMed ID: 21536977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for inhibitory deficits in the prefrontal cortex in schizophrenia.
    Radhu N; Garcia Dominguez L; Farzan F; Richter MA; Semeralul MO; Chen R; Fitzgerald PB; Daskalakis ZJ
    Brain; 2015 Feb; 138(Pt 2):483-97. PubMed ID: 25524710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.